Core Scientific, Inc./tx Cash Flow Statement

Cash Flow Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -12.21M47.27M-2146.31M-246.50M-1315.05M
Share-based Compensation 3.04M38.94M182.89M58.89M51.92M
Deferred Taxes 9.53M-18.52M
Gains from Investment Securities 1.83M93.96M30.32M3.66M6.04M
Asset Writedowns and Impairment 0.62M9.00M
Cash from Operations -23.77M-56.73M205.19M65.11M42.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.83M0.44M6.92M
Amortization of Deferred Charges 1.30M7.27M7.13M0.75M3.76M
Depreciation & Amortization (CF) 9.40M33.36M225.26M96.00M113.20M
Change in Working Capital
Change in Receivables 1.30M7.42M7.86M0.77M-0.66M
Change in Account Payables -1.77M-21.99M26.71M118.91M-12.27M
Change in Accured Expenses 1.62M56.20M17.23M130.38M1.88M
Other Working Capital Changes 30.01M34.08M-51.82M18.35M20.39M
Investing Activities
Capital Expenditures 2.54M383.98M16.16M94.96M
Sales of Property, Plant and Equipment 14.00M
Change in Intangibles 10.85M
Cash from Investing Activities -15.14M-423.84M-590.78M-3.00M-95.19M
Financing Activities
Other financing activities 6.47M2.53M
Cash from Financing Activities 40.72M603.53M306.15M-44.65M819.57M
Additional items
Change in Cash 1.81M122.96M-79.44M17.47M767.27M
Free Cash Flow -26.31M-56.73M-178.79M48.95M-52.06M
Net Cash Flow 1.81M122.96M-79.44M17.47M767.27M